Skip to content
10-K

Annual Report

ENTASIS THERAPEUTICS HOLDINGS INC.

0001558370-22-002788

← back to feed
Filed
Mar 3, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2021 · Dec 31, 2021 43.34M sh
Shares Diluted FY 2021 · Dec 31, 2020 24.06M sh
Capex FY 2021 · Dec 31, 2021 $70K
Operating Cash Flow FY 2021 · Dec 31, 2021 −$42.97M
Cash And Equivalents FY 2021 · Dec 31, 2021 $32.31M
Stockholders Equity FY 2021 · Dec 31, 2021 $31.21M
Current Liabilities FY 2021 · Dec 31, 2021 $9.71M
Total Liabilities FY 2021 · Dec 31, 2021 $9.71M
Current Assets FY 2021 · Dec 31, 2021 $39.82M
Total Assets FY 2021 · Dec 31, 2021 $40.92M
Eps Diluted FY 2021 · Dec 31, 2021 −$1.09
Eps Diluted FY 2021 · Dec 31, 2020 −$2.10
Eps Basic FY 2021 · Dec 31, 2021 −$1.09
Eps Basic FY 2021 · Dec 31, 2020 −$2.10
Sga Expense FY 2021 · Dec 31, 2021 $15.21M
Rd Expense FY 2021 · Dec 31, 2021 $37.11M
Net Income FY 2021 · Dec 31, 2021 −$47.14M
Operating Income FY 2021 · Dec 31, 2021 −$52.32M